RC
HCAT icon

Rangeley Capital’s Health Catalyst HCAT Stock Holding History

Rangeley Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6K Buy
+15,880
New +$22.9K 0.03% 168

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rangeley Capital's HCAT Position: Q2 2026 in Review

Rangeley Capital opened a new position in Health Catalyst (HCAT) in Q2 2026: 15,880 shares worth $31.6K. The stake represents 0.03% of the portfolio and ranks #168 among its holdings.

127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Rangeley Capital held 15,880 shares of Health Catalyst worth $31.6K as of Q2 2026.
  • Health Catalyst was a new Rangeley Capital position in Q2 2026.
  • Health Catalyst made up 0.03% of Rangeley Capital's portfolio in Q2 2026, its #168 holding.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.